| Literature DB >> 29755573 |
Kyung Mi Jo1, Hyo Kyung Lim2, Jae Woong Sull1,3, Eugene Choi4, Ji-Sook Lee5, Mee Ae Cheong1, Min Hwa Hong1, Yoori Kim1, In Sik Kim1,2.
Abstract
BACKGROUND: The pathogenesis of asthma, which is an allergic lung disease, is associated with a variety of allergens such as house dust mite, pollen, and mould, IgE containing serum IgE and allergen-specific-IgE, and inflammatory cytokines including thymus and activation-regulated chemokine (TARC)/CCL17. Because aging is an essential factor in the pathogenesis of asthma, we examined biomarkers related to asthmatic subjects depending on age.Entities:
Keywords: Aging; Allergen-specific IgE; Asthma; TARC
Year: 2018 PMID: 29755573 PMCID: PMC5936629 DOI: 10.1186/s12979-018-0118-7
Source DB: PubMed Journal: Immun Ageing ISSN: 1742-4933 Impact factor: 6.400
Characteristics of the study population
| Normal | Asthma | ||
|---|---|---|---|
| Number of subjects (female/male) | 106(62/44) | 121 (66/55) | |
| Age (years) | 45.3 ± 12.7(19~ 72) | 50.8 ± 16.7 (15~ 84) | |
| FEV1§ | 4.1 ± 0.9 (2.7~ 5.3)** | 2.1 ± 0.8 (1~ 4)** | |
| FEV1§ (% predicted) | 101.6 ± 11.9 (87.1~ 121.3)* | 81.4 ± 22.2 (34~ 125)* | |
| FVC∥ (% predicted) | 95.2 ± 11.5 (77.9~ 112.9) | 91.3 ± 17.8 (40~ 140) | |
| FEV1/FVC (%) | 91.6 ± 4.9 (84.8~ 97.9)** | 71.9 ± 14.2 (35~ 98)** | |
| Blood cells | Neutrophils | 55.3 ± 9.7 (28.5~ 75.4) | 59.5 ± 14.3 (27~ 92) |
| Lymphocytes | 35.7 ± 9.3 (20~ 67.3)** | 26.8 ± 11.0 (4~ 52)** | |
| Monocytes | 6.7 ± 3.2 (2.0~ 19.0)** | 7.0 ± 2.7 (1~ 17)** | |
| Eosinophils | 2.0 ± 1.4 (0~ 6.0)** | 5.7 ± 8.4 (0~ 55)** | |
| Basophils | 0.3 ± 0.3(0~ 1.3)* | 0.5 ± 0.5 (0~ 4)* | |
| BALF cells | Neutrophils | 2.0 ± 1.6 (0~ 5.1)** | 16.6 ± 26.7 (0~ 90)** |
| Lymphocytes | 10.6 ± 8.4 (1.0~ 29.2) | 16.9 ± 17.0 (0~ 69) | |
| Macrophage | 86.2 ± 10.4 (62.0~ 99.0)** | 59.9 ± 27.8 (3~ 95)** | |
| Eosinophils | 0.2 ± 0.6 (0~ 1.9) | 3.9 ± 8.5 (0~ 52) | |
| Basophils | 0 ± 0 (0~ 0) | 0.04 ± 0.1(0~ 1) | |
| Epithelial cells | 0.8 ± 1.0 (0~ 2.5) | 2.38 ± 9.6 (0~ 86) | |
| Total IgE | 92.8 ± 143.4(2.2~ 694.2)** | 376.4 ± 612.2 (2~ 3000)** | |
| Der p 1-specific IgE | 0.8 ± 2.1(0~ 10.4)* | 4.1 ± 15.3 (0~ 100)* | |
| IgE | Der p 1-specific IgE (class) | 0.4 ± 1.0(0~ 3) | 0.62 ± 1.2 (0~ 5) |
| Der f 1-specific IgE | 1.5 ± 4.4(0~ 23.4)** | 7.3 ± 19.5 (0~ 100)** | |
| Der f 1-specific IgE (class) | 0.8 ± 1.2(0~ 4) | 1.2 ± 1.5 (0~ 5) | |
FEV1§: forced expiratory volume in 1 second
FVC∥: forced vital capacity
Data are expressed as the means ± SD (the lowest value ~ the highest value)
*p < 0.05 and **p < 0.01 indicate statistically significant differences between the normal and asthma groups
Measurement of cytokine concentration of the study population
| Normal | Asthma | ||
|---|---|---|---|
| Serum | IL-4 | 297.3 ± 1185.1 (0~ 7126.6) | 342.0 ± 831.7 (0~ 4955) |
| IL-5 | 136.2 ± 526.9 (0~ 2744.7) | 189.7 ± 1184.7 (0~ 7399) | |
| IL-6 | 6.2 ± 22.2 (0~ 134.4) | 11.0 ± 12.2 (0~ 50) | |
| IL-8 | 46.2 ± 234.8 (0~ 1460.9) | 64.5 ± 155.5 (0~ 805) | |
| IL-10 | 29.9 ± 124.0 (0~ 723.2) | 16.9 ± 77.6 (0~ 435) | |
| MCP-1 | 466.9 ± 860.4 (8.9~ 3032.4)** | 2042.1 ± 1427.3 (246.9~ 8180.4)** | |
| TNF-α | 87.2 ± 135.1 (8.5~ 884.3)** | 9.5 ± 8.4 (0~ 38)** | |
| INF-γ | 48.6 ± 161.8 (0~ 945.1) | 52.6 ± 146.7(0~ 741) | |
| GM-CSF | 31.1 ± 36.6 (13.1~ 185.1) | 32.1 ± 5.1 (27.1~ 55.7) | |
| TARC | 9.0 ± 23.9 (0~ 150.3) | 4.9 ± 15.8 (0~ 64.7) | |
| RANTES | 685.3 ± 56.6 (601.4~ 857.7)** | 800.4 ± 98.0 (553.7~ 978.7)** | |
| MIP-1α | 81.2 ± 91.5 (11.0~ 338.2)** | 25.2 ± 43.7 (0~ 202.4)** | |
| BALF | IL-4 | 26.8 ± 54.5 (0~ 144) | 102.0 ± 191.2 (0~ 740) |
| IL-5 | 0.0 ± 0.0 (0~ 0) | 0.0 ± 0.0 (0~ 0) | |
| IL-6 | 1.7 ± 3.3 (0~ 8)* | 11.2 ± 23.8 (0~ 89)* | |
| IL-8 | 470.9 ± 626.1 (0~ 2041)** | 2682.1 ± 4417.5 (0~ 21,246)** | |
| IL-10 | 0.0 ± 0.0 (0~ 0) | 0.0 ± 0.0 (0~ 0) | |
| MCP-1 | 197.7 ± 265.7 (0~ 701)** | 936.7 ± 1268.5 (0~ 4452)** | |
| TNF-α | 0.0 ± 0.0 (0~ 0) | 0.0 ± 0.0 (0~ 0) | |
| INF-γ | 9.0 ± 14.6 (0~ 39) | 11.6 ± 15.6 (0~ 59) | |
| GM-CSF | 0.0 ± 0.0 (0~ 0) | 0.0 ± 0.0 (0~ 0) | |
| TARC | 0.0 ± 0.0 (0~ 0) | 2.7 ± 12.7 (0~ 73.1) | |
| RANTES | 0.0 ± 0.0 (0~ 0)** | 23.8 ± 40.1 (0~ 142.8)** | |
| MIP-1α | 0.0 ± 0.0 (0~ 0)** | 50.7 ± 84.9 (0~ 376.0)** | |
Different expression of the measured parameters among the asthmatic age groups
| Young adult group | Middle-aged adult group ( | Elderly adult group | ||
|---|---|---|---|---|
| Hb | 13.9 ± 2.0$$ | 13.6 ± 1.3 | 12.8 ± 1.3$$ | 0.007 |
| Hct | 41.2 ± 5.7$ | 40.1 ± 3.9 | 38.1 ± 4.0$ | 0.012 |
| ESR | 17.8 ± 17.3$ | 23.2 ± 24.3 | 34.7 ± 28.3$ | 0.036 |
| Der p1-specific IgE(class) | 1.12 ± 1.4*$ | 0.4 ± 1.1* | 0.43 ± 1.1$ | 0.042, 0.050 |
| FVC | 3.6 ± 1.0**$$ | 2.9 ± 0.7** | 2.4 ± 0.7$$ | $0.000, *0.001 |
| FEV1 | 3.0 ± 0.7**$$ | 2.1 ± 0.6**## | 1.5 ± 0.5$$## | $0.000, *0.000, #0.001 |
| FEV1/FVC | 80.0 ± 9.6$$ | 73.2 ± 13.1## | 63.6 ± 14.8$$## | $0.000, #0.004 |
| Serum TARC | 0.0 ± 0.0 | 0.0 ± 0.0# | 12.9 ± 23.9# | #0.045 |
Data are expressed as the means ± SD
*p < 0.05 and **p < 0.01 indicate between the young adult group and middle-aged group
#p < 0.05 and ##p < 0.01 indicate between the middle aged group and elderly group
$p < 0.05 and $$p < 0.01 indicate between the young adult group and elderly group
Correlation among the measured parameters in the total group and the elderly adult group of asthmatic subjects
| Total group | pb | Hct | ESR | FEV1/ FVC | Serum IL-6 | Serum TARC |
|---|---|---|---|---|---|---|
| Total IgE | ||||||
| Der p1-specific gE | ||||||
| Der p1-specific IgE(class) | ||||||
| Der f1-specific IgE | ||||||
| Der f1-specific IgE(class) | ||||||
| Elderly adult group | Hb | Hct | ESR | FEV1/ | S-IL-6 | S-TARC |
| Total IgE | ||||||
| Der p1-specific IgE | ||||||
| Der p1-specific IgE(class) | ||||||
| Der f1-specific IgE | ||||||
| Der f1-specific IgE(class) |
*correlation with p < 0.05
**correlation with p < 0.01